All In MedTech

FDA Clearance Tracker · P980016-S548

EVERA S DR ICD, EVERA S VR ICD, EVERA XT DR ICD, EVERA XT VR ICD

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 29, 2015 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 29, 2015

Approved

Time to decision

55 days

Received Sep 4, 2015. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P980016-S548
Device name
EVERA S DR ICD, EVERA S VR ICD, EVERA XT DR ICD, EVERA XT VR ICD
Applicant location
Mounds View, MN
Received
Sep 4, 2015
Decided
Oct 29, 2015
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P980016

Device type

Device class
Class III

Every decision under product code LWS

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THREE NEW ALTERNATE ICS TO BE USED IN THE DEVICES.

Source documents

Other decisions for Medtronic Cardiac Rhythm Disease Management

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.